TEC-话题@MedSci

#TEC#

484篇内容 | 2644人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652499, encodeId=4b2b1652499d3, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Nanotech：肿瘤免疫治疗重大突破，上海药物所李亚平等开发表观遗传调控纳米囊泡，改善肿瘤免疫治疗, objectType=article, longId=217850, objectId=134921e85030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=134921e85030, replyNumber=0, likeNumber=64, createdTime=2022-01-05, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=134921e85030, moduleTitle=Nat Nanotech：肿瘤免疫治疗重大突破，上海药物所李亚平等开发表观遗传调控纳米囊泡，改善肿瘤免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=134921e85030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652490, encodeId=6b8e165249089, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=BioNTech 计划开发一种 mRNA 疫苗来预防疟疾, objectType=article, longId=215299, objectId=943c21529991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=943c21529991, replyNumber=0, likeNumber=95, createdTime=2022-07-16, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=943c21529991, moduleTitle=BioNTech 计划开发一种 mRNA 疫苗来预防疟疾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=943c21529991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652482, encodeId=34ec165248284, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理, objectType=article, longId=211486, objectId=7d0921148685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0921148685, replyNumber=0, likeNumber=77, createdTime=2022-04-01, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0921148685, moduleTitle=Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0921148685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652505, encodeId=1cae165250574, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病, objectType=article, longId=219369, objectId=9a0121936917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0121936917, replyNumber=0, likeNumber=92, createdTime=2022-09-28, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0121936917, moduleTitle=Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0121936917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652492, encodeId=65ba165249278, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！, objectType=article, longId=215591, objectId=5479215591c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5479215591c2, replyNumber=0, likeNumber=81, createdTime=2021-10-22, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5479215591c2, moduleTitle=Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5479215591c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652485, encodeId=01be1652485b7, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应, objectType=article, longId=212480, objectId=b2a22124805f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a22124805f, replyNumber=0, likeNumber=118, createdTime=2021-09-18, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a22124805f, moduleTitle=ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a22124805f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652496, encodeId=ccfb16524965c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Adjuvance Technologies公布其下一代皂苷佐剂的首批临床结果, objectType=article, longId=216312, objectId=b4ff216312f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4ff216312f7, replyNumber=0, likeNumber=103, createdTime=2022-04-30, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4ff216312f7, moduleTitle=Adjuvance Technologies公布其下一代皂苷佐剂的首批临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4ff216312f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652506, encodeId=51dc1652506c4, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Polyene phosphatidylcholine protects against radiation induced tissue injury without affecting radiotherapeutic efficacy in lung , objectType=article, longId=221038, objectId=857b22103837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=857b22103837, replyNumber=0, likeNumber=72, createdTime=2022-03-19, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=857b22103837, moduleTitle=Polyene phosphatidylcholine protects against radiation induced tissue injury without affecting radiotherapeutic efficacy in lung , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=857b22103837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652481, encodeId=ba19165248105, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=美国FDA批准辉瑞/BioNTech新冠疫苗用于12-15岁青少年, objectType=article, longId=211125, objectId=10da2111256e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10da2111256e, replyNumber=0, likeNumber=77, createdTime=2022-02-23, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10da2111256e, moduleTitle=美国FDA批准辉瑞/BioNTech新冠疫苗用于12-15岁青少年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10da2111256e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652510, encodeId=6ddd1652510f5, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请, objectType=article, longId=293053, objectId=e61729305300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e61729305300, replyNumber=0, likeNumber=89, createdTime=2022-02-24, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e61729305300, moduleTitle=Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e61729305300)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652515, encodeId=f0a616525153b, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty, objectType=article, longId=295529, objectId=9c5d2955294a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5d2955294a, replyNumber=0, likeNumber=88, createdTime=2022-03-26, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5d2955294a, moduleTitle=辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5d2955294a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652503, encodeId=0b09165250366, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用, objectType=article, longId=218969, objectId=c1c72189695d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1c72189695d, replyNumber=0, likeNumber=85, createdTime=2022-07-17, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1c72189695d, moduleTitle=辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1c72189695d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652465, encodeId=b3d31652465ac, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=辉瑞/BioNTech疫苗可中和巴西新冠病毒变种, objectType=article, longId=208209, objectId=afc92082093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afc92082093c, replyNumber=0, likeNumber=59, createdTime=2021-05-13, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afc92082093c, moduleTitle=辉瑞/BioNTech疫苗可中和巴西新冠病毒变种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afc92082093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652466, encodeId=880b16524663e, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=辉瑞/ BioNTech COVID-19疫苗的真实世界证据, objectType=article, longId=208451, objectId=1d6420845140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d6420845140, replyNumber=0, likeNumber=48, createdTime=2021-05-06, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d6420845140, moduleTitle=辉瑞/ BioNTech COVID-19疫苗的真实世界证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d6420845140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652487, encodeId=1a73165248e30, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Alvotech启动Stelara® (Ustekinumab)拟议生物仿制药AVT04的临床研究, objectType=article, longId=213917, objectId=365621391e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365621391e66, replyNumber=0, likeNumber=122, createdTime=2021-11-02, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365621391e66, moduleTitle=Alvotech启动Stelara® (Ustekinumab)拟议生物仿制药AVT04的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=365621391e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652472, encodeId=6b8a16524e2d3, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=艾伯维指控Alvotech窃取修美乐商业机密, objectType=article, longId=209489, objectId=a3022094894b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3022094894b, replyNumber=0, likeNumber=76, createdTime=2021-11-19, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3022094894b, moduleTitle=艾伯维指控Alvotech窃取修美乐商业机密, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3022094894b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652471, encodeId=324816524e14d, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=辉瑞/BioNTech新冠疫苗保护期6个月有效率仍达91.3%, objectType=article, longId=209343, objectId=5e5c20934309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e5c20934309, replyNumber=0, likeNumber=97, createdTime=2022-01-05, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e5c20934309, moduleTitle=辉瑞/BioNTech新冠疫苗保护期6个月有效率仍达91.3%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e5c20934309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652473, encodeId=3dd816524e3c8, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化, objectType=article, longId=209881, objectId=f125209881cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f125209881cf, replyNumber=0, likeNumber=84, createdTime=2021-07-13, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f125209881cf, moduleTitle=Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f125209881cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652493, encodeId=5f6f1652493cf, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。, objectType=article, longId=215785, objectId=9da7215e85e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da7215e85e5, replyNumber=0, likeNumber=104, createdTime=2022-04-07, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da7215e85e5, moduleTitle=Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da7215e85e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652483, encodeId=0e1b16524839d, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, objectType=article, longId=211472, objectId=bfc62114e25e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc62114e25e, replyNumber=0, likeNumber=80, createdTime=2022-03-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc62114e25e, moduleTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc62114e25e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TEC

2020-05-29

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Nanotech：肿瘤免疫治疗重大突破，上海药物所李亚平等开发表观遗传调控纳米囊泡，改善肿瘤免疫治疗

2022-01-05

shock_melon (审核中...)

前往app查看评论内容

#TEC#

BioNTech 计划开发一种 mRNA 疫苗来预防疟疾

2022-07-16

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理

2022-04-01

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病

2022-09-28

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！

2021-10-22

shock_melon (审核中...)

前往app查看评论内容

#TEC#

ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应

2021-09-18

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Adjuvance Technologies公布其下一代皂苷佐剂的首批临床结果

2022-04-30

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Polyene phosphatidylcholine protects against radiation induced tissue injury without affecting radiotherapeutic efficacy in lung

2022-03-19

shock_melon (审核中...)

前往app查看评论内容

#TEC#

美国FDA批准辉瑞/BioNTech新冠疫苗用于12-15岁青少年

2022-02-23

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请

2022-02-24

shock_melon (审核中...)

前往app查看评论内容

#TEC#

辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty

2022-03-26

shock_melon (审核中...)

前往app查看评论内容

#TEC#

辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用

2022-07-17

shock_melon (审核中...)

前往app查看评论内容

#TEC#

辉瑞/BioNTech疫苗可中和巴西新冠病毒变种

2021-05-13

shock_melon (审核中...)

前往app查看评论内容

#TEC#

辉瑞/ BioNTech COVID-19疫苗的真实世界证据

2021-05-06

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Alvotech启动Stelara® (Ustekinumab)拟议生物仿制药AVT04的临床研究

2021-11-02

shock_melon (审核中...)

前往app查看评论内容

#TEC#

艾伯维指控Alvotech窃取修美乐商业机密

2021-11-19

shock_melon (审核中...)

前往app查看评论内容

#TEC#

辉瑞/BioNTech新冠疫苗保护期6个月有效率仍达91.3%

2022-01-05

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化

2021-07-13

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。

2022-04-07

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果

2022-03-21

科室
- - 订阅+
  - 更多科室
工具
服务